Deirdre Connelly
Eli Lilly's U.S. president is jumping ship to join GlaxoSmithKline as North American pharmaceuticals chief. Deirdre Connelly (above) joined Lilly in 1983 as a sales rep and proceeded to move up the ladder. In 2003, she became executive director of HR for Lilly's U.S. affiliate, and she was tapped to lead the entire U.S. operation in 2005. As Glaxo's president of North American Pharmaceuticals starting Feb. 9, Connelly will report directly to CEO Andrew Witty (photo), taking the place of Chris Viehbacher (photo), who left to become CEO of Sanofi-Aventis. Lilly tapped Enrique Conterno (photo) to take her place.
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
